Skip to main content

A Plant License – AUTM Annual Conference

The anatomy of a plant license is different from that of a biotechnology, pharmaceutical, or medical devices license. Different types of intellectual property protect plants, so drafting associated licenses can...

OUP Faculty Virtual Office Hours

If you're a faculty member with intellectual property disclosure, sign up for a one-on-one meeting to discuss your idea with an OUP member. During these sessions, OUP can answer questions...

CTL@WCM Office Hours with Donna Rounds

CTL@WCM Virtual Office hours are open to all who wish to gain more information about the advancement of their patent filings, to discuss their technology venture project with a one-on-one...

CTL@WCM Special Panel on Women’s Health

From reproductive health menopause to mental health, more attention is being paid to women’s health issues as they are becoming less taboo. As of 2021, the women’s health segment accounts...

2022 Startup Financing Trends

OUP is pleased to invite you to our annual startup financing trends webinar.   Join Manny Stockman and Mitra Miri of OUP’s investment team to discuss startup financing trends to...

Alexandria in NYC: Overview + Breakfast

Bioventure eLab 1157 York Avenue, New York, NY, NY, United States

Weill Cornell Medicine Enterprise Innovation is excited to welcome to campus representatives from Alexandria Real Estate Equities: Jenna Foger – SVP, Science & Technology Whitney Snider, MD MBA – VP,...

CTL@WCM Office Hours with Brian Kelly

CTL@WCM Virtual Office hours are open to all who wish to gain more information about the advancement of their patent filings. You will discuss technology venture projects in a one-on-one...

CTL@WCM Office Hours with Brian Kelly

CTL@WCM Virtual Office hours are open to all who wish to gain more information about the advancement of their patent filings. You will discuss technology venture projects in a one-on-one...

CTL@WCM Special Panel on Drug Repurposing

Can you teach an old drug new tricks? Recent successes in repositioning existing drugs – from esketamine for treatment-resistant depression to remdesivir – originally developed to treat hepatitis C, tested...